HOMOLOGOUS RECOMBINATION REPAIR TESTING PATTERNS AND BARRIERS IN METASTATIC HORMONE-SENSITIVE AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER ACROSS EUROPE: A REAL-WORLD SURVEY

被引：0
|
作者：
Castro, E. [1 ]
Orji, C. [2 ]
Ribbands, A. [3 ]
Butcher, J. [3 ]
Walley, M. [4 ]
Li, W. [5 ]
Ghate, S. [2 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Merck & Co Inc, Rahway, NJ USA
[3] Adelphi Real World, Bollington, Cheshire, England
[4] Adelphi Real World, Macclesfield, Cheshire, England
[5] AstraZeneca Pharmaceut LP, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD8
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [41] Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
    Kelly, R.
    Wong, S. S. L.
    Shapiro, J.
    Weickhardt, A. J.
    Parente, P.
    Azad, A.
    Uccellini, A.
    Torres, J.
    Parnis, F.
    Kwan, E.
    Brown, S.
    Steer, C.
    Warren, M.
    Gibbs, P.
    Anton, A.
    Tran, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1498 - S1499
  • [42] REAL-WORLD OUTCOMES AND TREATMENTS PATTERNS OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: AN ITALIAN RETROSPECTIVE STUDY
    Danesi, V
    Roncadori, A.
    Massa, I
    Balzi, W.
    Maltoni, R.
    Farolfi, A.
    VALUE IN HEALTH, 2022, 25 (12) : S49 - S49
  • [43] Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive Stage
    Loriot, Yohann
    Fizazi, Karim
    EUROPEAN UROLOGY FOCUS, 2024, 10 (04): : 511 - 513
  • [44] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [45] Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide
    Scailteux, L. M.
    Vincendeau, S.
    Gravis, G.
    Mathieu, R.
    Balusson, F.
    Kerbrat, S.
    Oger, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 10 - 11
  • [46] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [47] REAL-WORLD TREATMENT PATTERNS AND CARE PATHWAYS IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Lam, J.
    Yang, C.
    Kaiser, C.
    Wong, W.
    VALUE IN HEALTH, 2018, 21 : S41 - S41
  • [48] Prediction of Time to Castration-Resistant Prostate Cancer Using Bone Scan Index in Men with Metastatic Hormone-Sensitive Prostate Cancer
    Miyoshi, Yasuhide
    Yoneyama, Shuko
    Kawahara, Takashi
    Hattori, Yusuke
    Teranishi, Jun-ichi
    Ohta, Jun-ichi
    Takebayashi, Shigeo
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Uemura, Hiroji
    UROLOGIA INTERNATIONALIS, 2017, 99 (04) : 400 - 405
  • [49] Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes
    Olmos, D.
    Lorente, D.
    Alameda, D.
    Cattrini, C.
    Romero-Laorden, N.
    Lozano, R.
    Lopez-Casas, P. P.
    Jambrina, A.
    Capone, C.
    Vanden Broecke, A. M.
    Trevisan, M.
    Van Sanden, S.
    Juergens, A.
    Herrera-Imbroda, B.
    Castro, E.
    ANNALS OF ONCOLOGY, 2024, 35 (05) : 458 - 472
  • [50] Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
    Darren M. C. Poon
    Kuen Chan
    S. H. Lee
    T. W. Chan
    Henry Sze
    Eric K. C. Lee
    Daisy Lam
    Michelle F. T. Chan
    BMC Urology, 16
12345